AODWE-005 Golimumab induction for moderate to severe ulcerative colitis: patient-reported outcomes of partial mayo score results from the go-colitis study
AODWE-005 Golimumab induction for moderate to severe ulcerative colitis: patient-reported outcomes of partial mayo score results from the go-colitis study